Epinephrine Bitartrate

重酒石酸肾上腺素

Report date: 2025/07/04 16:55:27
NME

Base Information

Drug NameEpinephrine Bitartrate
Drug Alias Name酸式酒石酸肾上腺素Adrenaline BitartrateEpirenamine BitartrateAdrenaline Acid TartrateEpinephrine Acid Tartrate +[7] 
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors agonists
TargetsAdrenergic receptors
Therapy Area/IndicationsRejection of lung transplantationHemorrhageImmune System Diseases +[9] 
Global Approved IndicationsAsthma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1956/03/09
Country/TerritoryUnited StatesSingaporeSouth Korea +[5] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator Companies3m Healthcare Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChinese University Of Hong Kong (Cuhk)University Of Maryland, Baltimore
Inactive CompaniesUniversity Of LouisvilleRutgers University3m Healthcare Ltd +[4] 
Active IndicationsRejection of lung transplantationHemorrhageDiabetes Complications +[5] 
Inactive IndicationsImmune System DiseasesAsthmaPeptic Ulcer Hemorrhage +[4] 

Other Information

ATC CodeA01AD01B02BC09C01CA24 +[6] 
Related LinksWikipediaDrugBankKEGG